What is the market doing?
What the tape says about ELVN
Enliven Therapeutics, Inc. is +240% over the past year while the S&P 500 is +23%: 217 points ahead of the market.
+240%
1-year return · S&P 500 +23%
- vs 200-day average
- +77%
vs 200-day average · a clear uptrend
- RSI (14)
- 54
RSI (14) · neutral
- Below its 52-week high
- −0.47%
Below its 52-week high
Details›
- Last close2026-08-26
- $60.87
- 1 monthS&P 500 +3.7%
- +15%
- 1 yearS&P 500 +23%
- +240%
- 5 yearsS&P 500 +87%
- +176%
- vs 50-day average$50.67
- +20%
- 52-week high
- $61.15
- 52-week low
- $15.14
- Annualised volatility
- 72%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$52M
| Year | Return |
|---|---|
| 2026 (year to date) | +295% |
| 2025 | −32% |
| 2024 | +63% |
| 2023 | −15% |
| 2022 | +82% |
| 2021 | −90% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 3 of 6 | +2.7% |
| Feb | 6 | 4 of 6 | +5.3% |
| Mar | 6 | 4 of 6 | +4.8% |
| Apr | 7 | 2 of 7 | −6.4% |
| May | 7 | 2 of 7 | +14% |
| Jun | 7 | 6 of 7 | +6.3% |
| Jul | 7 | 2 of 7 | −7.7% |
| Aug | 7 | 4 of 7 | −1.2% |
| Sep | 6 | 3 of 6 | +12% |
| Oct | 6 | 3 of 6 | +12% |
| Nov | 6 | 1 of 6 | +3.6% |
| Dec | 6 | 1 of 6 | −11% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.